S100B and major depressive disorder: Our systematic review aims to compare results on circulating S100B levels in five major psychiatric disorders with shared genetic susceptibility: schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, and autistic spectrum disorder.